1. Home
  2. ARR vs WVE Comparison

ARR vs WVE Comparison

Compare ARR & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ARMOUR Residential REIT Inc.

ARR

ARMOUR Residential REIT Inc.

N/A

Current Price

$17.78

Market Cap

2.0B

Sector

Real Estate

ML Signal

N/A

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

N/A

Current Price

$14.10

Market Cap

2.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ARR
WVE
Founded
2008
2012
Country
United States
Singapore
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.4B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
ARR
WVE
Price
$17.78
$14.10
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
15
Target Price
$18.00
$31.47
AVG Volume (30 Days)
3.1M
2.2M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
16.18%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$3,704,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$8.84
$119.93
P/E Ratio
$27.18
N/A
Revenue Growth
N/A
149.43
52 Week Low
$13.18
$5.28
52 Week High
$19.31
$21.73

Technical Indicators

Market Signals
Indicator
ARR
WVE
Relative Strength Index (RSI) 48.67 54.83
Support Level $17.38 $12.53
Resistance Level $18.54 $14.56
Average True Range (ATR) 0.38 0.77
MACD -0.02 0.02
Stochastic Oscillator 67.63 52.67

Price Performance

Historical Comparison
ARR
WVE

About ARR ARMOUR Residential REIT Inc.

ARMOUR Residential REIT Inc operate in the U.S. and invest in fixed rate residential, adjustable rate and hybrid adjustable rate residential MBS issued or guaranteed by U.S. GSEs or guaranteed by Ginnie Mae. It also invest in U.S. Treasury Securities and money market instruments.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: